MTP Therapeutics Overview
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
MTP Therapeutics General Information
Description
Developer of anti-cancer drugs designed for the treatment of solid tumors. The company specializes in the development of a peptide antagonist of neuropilin that is capable of inhibiting the proliferation of tumor cells, migration, and angiogenesis, enabling clinicians to provide better treatment for cancerous tumors.
Contact Information
Corporate Office
- Strasbourg
- France
Corporate Office
- Strasbourg
- France
MTP Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 01-Aug-2023 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2013 | Completed | Startup | |||
| 1. Grant | 27-Sep-2011 | $69.2K | Completed | Startup |
MTP Therapeutics FAQs
-
Where is MTP Therapeutics headquartered?
MTP Therapeutics is headquartered in Strasbourg, France.
-
What industry is MTP Therapeutics in?
MTP Therapeutics’s primary industry is Drug Discovery.
-
Is MTP Therapeutics a private or public company?
MTP Therapeutics is a Private company.
-
What is MTP Therapeutics’s current revenue?
The current revenue for MTP Therapeutics is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process